(Q39683268)

14 September 2017

title

Use of complementary and alternative medicine by chinese women with breast cancer (English)

1 reference

14 September 2017

1 reference

2

Xiao-Ou Shu

1 reference

14 September 2017

Yong Cui

1

1 reference

14 September 2017

Yutang Gao

3

1 reference

14 September 2017

Wanqing Wen

4

1 reference

14 September 2017

Zhi-Xian Ruan

5

1 reference

14 September 2017

Fan Jin

6

1 reference

14 September 2017

Wei Zheng

7

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Breast Cancer Research and Treatment

14 September 2017

published in

1 reference

14 September 2017

volume

85

1 reference

14 September 2017

issue

3

1 reference

14 September 2017

page(s)

263-270

1 reference

https://scigraph.springernature.com/pub.10.1023/b:brea.0000025422.26148.8d

14 September 2017

exact match

0 references

cites work

Phase II trial of weekly single-agent paclitaxel in platinum/paclitaxel-refractory ovarian cancer.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

Alternative medicine use worldwide: the International Union Against Cancer survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

The prevalence of complementary/alternative medicine in cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Diagnosing lead poisoning

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Use of alternative medicine by women with early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Cancer patients use of nonproven therapy: a 5-year follow-up study.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Healers and strangers. Immigrant attitudes toward the physician in America--a relationship in historical perspective

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Alternative therapies used by women with breast cancer in four ethnic populations

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Complementary and alternative medicine in early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Traditional Chinese medicine in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Toxic heavy metals and undeclared drugs in Asian herbal medicines

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Global cancer statistics in the year 2000.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Prevalence of complementary therapy use by women with breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Between two worlds: the use of traditional and Western health services by Chinese immigrants

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Illness management strategies among Chinese immigrants living with arthritis

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Association of body size and fat distribution with risk of breast cancer among Chinese women.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Caring (really) for patients who use alternative therapies for cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Complementary, alternative, integrative, or unconventional medicine?

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

Determinants of the use of complementary therapies by patients with cancer.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000025422.26148.8D

7 January 2021

10.1023/B:BREA.0000025422.26148.8D

Identifiers

DOI

1 reference

Dimensions Publication ID

14 September 2017

1042777879

0 references

1 reference